S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80

3 High-Yield Dividend Stocks to Buy for Income

Friday, April 30, 2021 | Sean Sechler
3 High-Yield Dividend Stocks to Buy for IncomeIt’s easy for investors to be drawn to the allure of stocks that offer high dividend yields. After all, a stock’s dividend yield essentially tells you how much dividend income you will be getting in comparison to the current stock price. With that said, chasing high yields can be dangerous if you aren’t confident in the quality of the company you are buying. A high dividend yield can potentially signify a company is dealing with issues that have caused the stock price to fall substantially. There’s always the possibility that a company will cut a dividend too if they are having financial problems. That’s why it’s so important to only buy high-yield dividend stocks that have a strong business model and generate enough cash flow to sustain the payout.

If you are interested in adding income to your investment portfolio, reliable high-yield dividend stocks are a great option. We’ve put together a list of 3 high-yield dividend stocks to buy for income below to help you sort through the “dividend traps” and only select the best quality names for your portfolio. Keep reading below to learn more.

Walgreens Boots Alliance (NASDAQ:WBA)

First on our list of high-yield dividend stocks to buy is Walgreens Boots Alliance, a stock that currently offers investors a 3.57% dividend yield. As one of the largest pharmacies in the world, investors can count on this company to generate substantial cash flow to maintain its dividend thanks to nearly 13,500 retail stores that provide products with steady demand. While Walgreens does face competition in the pharmacy space from companies like Amazon, investors should applaud the company’s recent strategic moves. That includes the sale of its wholesale distribution business Alliance Healthcare and expanding its VillageMD partnership that will make Walgreens the first national pharmacy chain to offer full-service doctor offices co-located at its stores.

It’s also worth noting that Walgreens Boots Alliance is a dividend aristocrat, as the company has increased its dividend payment for 44 consecutive years. The company is also playing a key role in one of the largest vaccination programs in recent memory as the world recovers from the COVID-19 pandemic. Keep in mind that as things return to normal, Walgreens should see an uptick in sales as people start to pursue more elective procedures and physician visits. Finally, the company delivered a strong Q1 earnings beat at the end of March to help investors gain confidence that the company is heading in the right direction.

Exxon Mobil Corp (NYSE:XOM)

Energy companies faced difficult circumstances in 2020, especially due to massive bouts of volatility in the price of oil. However, Exxon Mobil has recovered nicely in 2021 and could be a solid high-yield dividend stock for investors that believe the rebound in the energy sector still has legs. Exxon is one of the world’s largest publicly traded integrated oil companies and one of the biggest players in the global energy sector. The company has recently taken steps to protect its dividend, and the way that crude oil prices have performed so far should help investors have confidence that things are looking up for Exxon Mobil.

While it’s true that the world is undergoing a shift towards renewable energy sources, this transition will take years if not decades to complete. Exxon Mobil also has some nice potential with offshore oil projects in Brazil, Guyana, Mozambique, and Papua New Guinea. The bottom line here is that investors are getting compensated for the risk associated with the energy sector thanks to a 5.99% dividend yield. As of now, things are looking good for Exxon Mobil and the energy sector should remain stable for the near future, so why not collect a nice dividend from an industry-leading company?

Cardinal Health (NYSE:CAH)

Last up is Cardinal Health, which is a leading healthcare services and products company. It’s one of the "big three" companies that control 90% of the U.S. market share in the pharmaceutical distribution industry. Cardinal Health connects manufacturers of pharmaceuticals and medical supplies with a broad range of customers including pharmacies, physician offices, hospitals, clinical labs, and more. We all know how important the healthcare industry is after the pandemic, and Cardinal Health should be a big beneficiary of an uptick in elective procedures as more people get vaccinated.

The stock offers investors a 3.24% dividend yield at this time and is another dividend aristocrat, which is great to see if you are an investor looking for consistent income. Keep in mind that President Joe Biden will likely be building upon the Affordable Care Act in the coming months, which is another potentially positive catalyst for the stock price.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Walgreens Boots Alliance (WBA)
2.63 of 5 stars
Exxon Mobil (XOM)
2.1717 of 5 stars
Cardinal Health (CAH)
2.2155 of 5 stars
Compare These Stocks  Add These Stocks to My Watchlist 

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastIs The Market Near a Bottom, Does it Matter?

Today’s interview is a little different, in that you get a LOT of market perspective from someone who’s been analyzing stocks from the ground up, for more than three decades. In this conversation, Kate chats with Nancy Zambell, the chief analyst for the Cabot Money Club Letter - and Nancy has a really deep and varied background in the financial industry - as she mentions in this interview, she’s been a banker, real estate professional, and a stock market analyst.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.